Calain Philippe, Chaine Jean-Paul, Johnson Eliaser, Hawley Mary-Lou, O'Leary Michael J, Oshitani Hitoshi, Chaignat Claire-Lise
WHO Western Pacific Regional Office, Manila, Philippines.
Vaccine. 2004 Jun 23;22(19):2444-51. doi: 10.1016/j.vaccine.2003.11.070.
Control measures to limit the spread of a cholera outbreak in Pohnpei Island (Micronesia), included mass vaccination with the single-dose live-attenuated oral cholera vaccine CVD 103-HgR as a potential adjunct measure. The outbreak provided a unique opportunity to evaluate the practicality of use and effectiveness of this vaccine. Under field conditions encountered in Pohnpei, crude vaccine efficacy was estimated at 79.2% (95% CI: 71.9-84.6%) in the target population. Retrospective analysis suggests that mass vaccination with oral cholera vaccines can be a useful adjunct tool for controlling outbreaks, particularly if implemented early in association with other standard control measures.
为限制霍乱疫情在波纳佩岛(密克罗尼西亚)的传播而采取的控制措施,包括大规模接种单剂量减毒口服霍乱疫苗CVD 103-HgR作为一项潜在的辅助措施。此次疫情为评估该疫苗的实用性和有效性提供了一个独特的机会。在波纳佩岛实际遇到的现场条件下,目标人群中粗疫苗效力估计为79.2%(95%置信区间:71.9 - 84.6%)。回顾性分析表明,口服霍乱疫苗大规模接种可以成为控制疫情的一项有用辅助工具,特别是如果与其他标准控制措施联合在早期实施的话。